Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism C2 inhibitors(complement C2 inhibitors), C4B inhibitors(Complement factor C4-B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hereditary Complement Deficiency Diseases | Preclinical | US | - |